AbCellera Biologics Inc. (ABCL)
AbCellera Biologics Max Pain By Strike
ABCL trades at $4.58, 14.5% above the near-term max pain of $4 expiring Aug 15, 2025 (-1 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($1-$4), reflecting growing call interest at higher strikes. Key magnetic zone at 4 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
AbCellera Biologics Max Pain By Expiry
Max pain for ABCL shows an upward trend from 1 to 4, suggesting bullish positioning in longer-dated options. The 94% spread signals divergent expectations across timeframes. Most levels below 4.58 may cap rallies. Strong magnetic level at 4 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 4 | -0.58 (-12.66%) |
| Sep 19, 2025 | 4 | -0.58 (-12.66%) |
| Oct 17, 2025 | 4 | -0.58 (-12.66%) |
| Jan 16, 2026 | 3 | -1.58 (-34.50%) |
| Apr 17, 2026 | 1 | -3.58 (-78.17%) |